MA-67211001
type: RegulatedAuthorization
node role: treeRoot
id:
  v: MA-67211001
meta:
  profile:
    v: http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-regulatedauthorization
    l: ch-idmp-regulatedauthorization
text:
  status:
    v: generated
  div:
    v: Generated Narrative: RegulatedAuthorization MA-67211001 Profile: RegulatedAuthorization identifier: Marketing Authorisation Number/67211001 subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-idmp/sid/pcid#Clinical Product Identifier#CH-01100869-0672110010000-0001; containedItemQuantity = 48 Tablet; description = 4 Blister zu 7 Tabletten in 1 Box type: Marketing Authorisation region: Switzerland status: approved statusDate: 2021-11-09 validityPeriod: 2021-11-09 --> (ongoing) holder: Organization Astellas Pharma AG regulator: Organization SMC Generated Narrative: Organization #holder-Astellas-Pharma-AG Profile: Organization identifier: Swissmedic Location Identifier/01100869, LOC Identifier/100010745, GLN Identifier/7601001000964 name: Astellas Pharma AG Generated Narrative: Organization #regulator-SMC Profile: Organization identifier: LOC Identifier/100010911, GLN Identifier/7601001398511 name: SMC
contained: Organization
  id:
    v: holder-Astellas-Pharma-AG
  meta:
    profile:
      v: http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-organization
      l: ch-idmp-organization
  identifier:
    system:
      v: https://www.swissmedic.ch/fhir/identifier/locations
      l: locations
    value:
      v: 01100869
  identifier:
    system:
      v: https://spor.ema.europa.eu/v1/locations
      l: locations
    value:
      v: 100010745
  identifier:
    system:
      v: urn:oid:2.51.1.3
      l: 2.51.1.3
    value:
      v: 7601001000964
  name:
    v: Astellas Pharma AG
contained: Organization
  id:
    v: regulator-SMC
  meta:
    profile:
      v: http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-organization
      l: ch-idmp-organization
  identifier:
    system:
      v: https://spor.ema.europa.eu/v1/locations
      l: locations
    value:
      v: 100010911
  identifier:
    system:
      v: urn:oid:2.51.1.3
      l: 2.51.1.3
    value:
      v: 7601001398511
  name:
    v: SMC
identifier:
  system:
    v: http://fhir.ch/ig/ch-idmp/sid/authno
    l: authno
  value:
    v: 67211001
subject:
  l: PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
  reference:
    v: PackagedProductDefinition/PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
type:
  coding:
    system:
      v: http://fhir.ch/ig/ch-idmp/CodeSystem/ch-authorisation-type-cs
      l: ch-authorisation-type-cs
    code:
      v: 756000002001
    display:
      v: Marketing Authorisation
region:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: CH
    display:
      v: Switzerland
status:
  coding:
    system:
      v: http://fhir.ch/ig/ch-idmp/CodeSystem/ch-SMC-authorisation-status
      l: ch-SMC-authorisation-status
    code:
      v: 756005010000001
    display:
      v: approved
status date:
  v: 2021-11-09
validity period:
  start:
    v: 2021-11-09
holder:
  l: holder-Astellas-Pharma-AG
  reference:
    v: #holder-Astellas-Pharma-AG
regulator:
  l: regulator-SMC
  reference:
    v: #regulator-SMC